Juan Pereira Macedo

Juan Pereira Macedo

Auto-generated profile, based on publicly available information

Juan Pereira Macedo

Institute of Plant Sciences, University of Bern, Bern, Switzerland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Journal of Parasitology Research
Verified
Journal Article
Open access
PDF file
MHMaria Fátima Horta
Maria Fátima Horta
BMBárbara Pinheiro Mendes
Bárbara Pinheiro Mendes
EREric Roma
Eric Roma
FNFátima Soares Motta Noronha
Fátima Soares Motta Noronha
JMJuan Pereira Macêdo
Juan Pereira Macêdo
LVLeda Quercia Vieira
Leda Quercia Vieira
Cutaneous leishmaniasis affects millions of people around the world. Several species ofLeishmaniainfect mouse strains, and murine models closely reproduce the cutaneous lesions caused by the parasite in humans. Mouse models have enabled studies on the pathogenesis and effector mechanisms of host resistance to infection. Here, we review the role of nitric oxide (NO), reactive oxygen species (ROS), and peroxynitrite (ONOO−) in the control of parasites by macrophages, which are both the host cells and the effector cells. We also discuss the role of neutrophil-derived oxygen and nitrogen reactive species during infection withLeishmania. We emphasize the role of these cells in the outcome of leishmaniasis early after infection, before the adaptive Th-cell immune response.

7 April 2016 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
EREric Roma
Eric Roma
JMJuan Pereira Macedo
Juan Pereira Macedo
GGGrazielle Ribeiro Goes
Grazielle Ribeiro Goes
JGJuliana Lauar Gonçalves
Juliana Lauar Gonçalves
WCWaldionê de Castro
Waldionê de Castro
LVLeda Quercia Vieira
Leda Quercia Vieira
Reactive oxygen species (ROS) protect the host against a large number of pathogenic microorganisms. ROS have different effects on parasites of the genus Leishmania: some parasites are susceptible to their action, while others seem to be resistant. The role of ROS in L. amazonensis infection in vivo has not been addressed to date. In this study, C57BL/6 wild-type mice (WT) and mice genetically deficient in ROS production by phagocytes (gp91phox−/−) were infected with metacyclic promastigotes of L. amazonensis to address the effect of ROS in parasite control. Inflammatory cytokines, parasite loads and myeloperoxidase (MPO) activity were evaluated. In parallel, in vitro infection of peritoneal macrophages was assessed to determine parasite killing, cytokine, NO and ROS production. In vitro results show induction of ROS production by infected peritoneal macrophages, but no effect in parasite killing. Also, ROS do not seem to be important to parasite killing in vivo, but they control lesion sizes at early stages of infection. IFN-γ, TNF-α and IL-10 production did not differ among mouse strains. Myeloperoxidase assay showed augmented neutrophils influx 6 h and 72 h post - infection in gp91phox−/− mice, indicating a larger inflammatory response in gp91phox−/− even at early time points. At later time points, neutrophil numbers in lesions correlated with lesion size: larger lesions in gp91phox−/− at earlier times of infection corresponded to larger neutrophil infiltrates, while larger lesions in WT mice at the later points of infection also displayed larger numbers of neutrophils. ROS do not seem to be important in L. amazonensis killing, but they regulate the inflammatory response probably by controlling neutrophils numbers in lesions.

13 November 2017 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
RSRemo S. Schmidt
Remo S. Schmidt
JMJuan P. Macêdo
Juan P. Macêdo
MSMichael E. Steinmann
Michael E. Steinmann
ASAmaia González Salgado
Amaia González Salgado
PBPeter Bütikofer
Peter Bütikofer
PMPascal Mäser
Pascal Mäser

3 January 2017 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CMChristoph Mathieu
Christoph Mathieu
JMJuan P Macêdo
Juan P Macêdo
DHDaniel Hürlimann
Daniel Hürlimann
CWCorina Wirdnam
Corina Wirdnam
AHAlexander C Haindrich
Alexander C Haindrich
DRDoris Rentsch
Doris Rentsch
For Trypanosoma brucei arginine and lysine are essential amino acids and therefore have to be imported from the host. Heterologous expression in Saccharomyces cerevisiae mutants identified cationic amino acid transporters among members of the T. brucei AAAP (amino acid/auxin permease) family. TbAAT5-3 showed high affinity arginine uptake (Km 3.6 ± 0.4 μM) and high selectivity for L-arginine. L-arginine transport was reduced by a 10-times excess of L-arginine, homo-arginine, canavanine or arginine-β-naphthylamide, while lysine was inhibitory only at 100-times excess, and histidine or ornithine did not reduce arginine uptake rates significantly. TbAAT16-1 is a high affinity (Km 4.3 ± 0.5 μM) and highly selective L-lysine transporter and of the compounds tested, only L-lysine and thialysine were competing for L-lysine uptake. TbAAT5-3 and TbAAT16-1 are expressed in both procyclic and bloodstream form T. brucei and cMyc-tagged proteins indicate localization at the plasma membrane. RNAi-mediated down-regulation of TbAAT5 and TbAAT16 in bloodstream form trypanosomes resulted in growth arrest, demonstrating that TbAAT5-mediated arginine and TbAAT16-mediated lysine transport are essential for T. brucei. Growth of induced RNAi lines could partially be rescued by supplementing a surplus of arginine or lysine, respectively, while addition of both amino acids was less efficient. Single and double RNAi lines indicate that additional low affinity uptake systems for arginine and lysine are present in T. brucei.

14 February 2012 in PLOS Neglected Tropical Diseases
Verified
Journal Article
Open access
PDF file
HSHelton Santiago
Helton Santiago
CLClaudia Z. Gonzalez Lombana
Claudia Z. Gonzalez Lombana
JMJuan P. Macedo
Juan P. Macedo
LULara Utsch
Lara Utsch
WTWagner Luiz Tafuri
Wagner Luiz Tafuri
LVLeda Q. Vieira
Leda Q. Vieira
•NO is considered to be a key macrophage-derived cytotoxic effector during Trypanosoma cruzi infection. On the other hand, the microbicidal properties of reactive oxygen species (ROS) are well recognized, but little importance has been attributed to them during in vivo infection with T. cruzi. In order to investigate the role of ROS in T. cruzi infection, mice deficient in NADPH phagocyte oxidase (gp91phox−/− or phox KO) were infected with Y strain of T. cruzi and the course of infection was followed. phox KO mice had similar parasitemia, similar tissue parasitism and similar levels of IFN-γ and TNF in serum and spleen cell culture supernatants, when compared to wild-type controls. However, all phox KO mice succumbed to infection between day 15 and 21 after inoculation with the parasite, while 60% of wild-type mice were alive 50 days after infection. Further investigation demonstrated increased serum levels of nitrite and nitrate (NOx) at day 15 of infection in phox KO animals, associated with a drop in blood pressure. Treatment with a NOS2 inhibitor corrected the blood pressure, implicating NOS2 in this phenomenon. We postulate that superoxide reacts with •NO in vivo, preventing blood pressure drops in wild type mice. Hence, whilst superoxide from phagocytes did not play a critical role in parasite control in the phox KO animals, its production would have an important protective effect against blood pressure decline during infection with T. cruzi. When pathogens enter their hosts, they are fought by several resistance strategies, including capture by phagocytes and the production of pathogen-toxic molecules. Nitric oxide, a free radical, has been extensively studied as one of these toxic molecules that successfully mediates intracellular parasite killing, including Trypanosoma cruzi, the protozoan parasite that causes Chagas' disease. On the other hand, reactive oxygen species also mediate resistance to several pathogens, mainly bacterial. In this study, we addressed the role of reactive oxygen species in the resistance to T. cruzi using gene-deficient mice, a species which phagocytes lack the ability to produce (phox−/− mice). We found that phagocyte-derived reactive oxygen species are not critical to mediate resistance to parasite in the knock-out animals. However, phox−/− mice presented higher mortality and lower blood pressure due to infection with T. cruzi than non-deficient mice. The blood pressure was restored to normal by an inhibitor of nitric oxide synthesis by phagocytes. We hypothesize that superoxide (one of the oxygen reactive species) controls blood pressure during infection with T. cruzi, by reacting with nitric oxide and preventing its action on blood vessels.

6 May 2015 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JMJuan P. de Macêdo
Juan P. de Macêdo
GBGabriela Schumann Burkard
Gabriela Schumann Burkard
MNMoritz Niemann
Moritz Niemann
MBMichael P. Barrett
Michael P. Barrett
HVHenri Vial
Henri Vial
PBPeter Bütikofer
Peter Bütikofer
Elucidating the mechanism of action of trypanocidal compounds is an important step in the development of more efficient drugs against Trypanosoma brucei. In a screening approach using an RNAi library in T. brucei bloodstream forms, we identified a member of the mitochondrial carrier family, TbMCP14, as a prime candidate mediating the action of a group of anti-parasitic choline analogs. Depletion of TbMCP14 by inducible RNAi in both bloodstream and procyclic forms increased resistance of parasites towards the compounds by 7-fold and 3-fold, respectively, compared to uninduced cells. In addition, down-regulation of TbMCP14 protected bloodstream form mitochondria from a drug-induced decrease in mitochondrial membrane potential. Conversely, over-expression of the carrier in procyclic forms increased parasite susceptibility more than 13-fold. Metabolomic analyses of parasites over-expressing TbMCP14 showed increased levels of the proline metabolite, pyrroline-5-carboxylate, suggesting a possible involvement of TbMCP14 in energy production. The generation of TbMCP14 knock-out parasites showed that the carrier is not essential for survival of T. brucei bloodstream forms, but reduced parasite proliferation under standard culture conditions. In contrast, depletion of TbMCP14 in procyclic forms resulted in growth arrest, followed by parasite death. The time point at which parasite proliferation stopped was dependent on the major energy source, i.e. glucose versus proline, in the culture medium. Together with our findings that proline-dependent ATP production in crude mitochondria from TbMCP14-depleted trypanosomes was reduced compared to control mitochondria, the study demonstrates that TbMCP14 is involved in energy production in T. brucei. Since TbMCP14 belongs to a trypanosomatid-specific clade of mitochondrial carrier family proteins showing very poor similarity to mitochondrial carriers of mammals, it may represent an interesting target for drug action or targeting. Human and animal trypanosomiases caused by Trypanosoma brucei parasites represent major burdens to human welfare and agricultural development in rural sub-Saharan Africa. Although the numbers of infected humans have decreased continuously during the last decades, emerging resistance and adverse side effects against commonly used drugs require an urgent need for the identification of novel drug targets and the development of new drugs. Using an unbiased genome-wide screen to search for genes involved in the mode of action of trypanocidal compounds, we identified a member of the mitochondrial carrier family, TbMCP14, as prime candidate to mediate the action of a group of anti-parasitic choline analogs against T. brucei. Ablation of TbMCP14 expression by RNA interference or gene deletion decreases the susceptibility of parasites towards the compounds while over-expression of the carrier shows the opposite effect. In addition, down-regulation of TbMCP14 protects mitochondria from drug-induced decrease in mitochondrial membrane potential and reduces proline-dependent ATP production. Together, the results demonstrate that TbMCP14 is involved in energy production in T. brucei, possibly by acting as a mitochondrial proline carrier, and reveal TbMCP14 as candidate protein for drug action or targeting.